From Episodic Tests to Continuous Hormone Tracking
Continuous hormone tracking is the use of noninvasive sensors and AI modeling to monitor shifting hormone patterns in real time, replacing occasional blood tests with ongoing, longitudinal readings across an entire cycle or life stage. Clair Health is positioning itself at the center of this shift with a jewelry-inspired wrist wearable that models estrogen, progesterone, LH and FSH without blood or urine. Instead of isolated lab draws, the device collects signals from 10 biosensors and more than 130 proprietary biomarkers to infer endocrine activity. Co-founder Jenny Duan notes that existing women’s health wearables record heart rate variability, sleep, steps and breathing, but ignore the hormonal signals that shape those metrics. By adding an endocrine data layer, Clair aims to move women’s health monitoring from snapshots to trends, enabling users and clinicians to see how hormones influence sleep, mood, metabolism, fertility and recovery over time.
Investor Confidence and the Hormone-Tracking Category
Clair Health’s USD 11.6 million (approx. RM54.0 million) seed round is as much a vote on a new category as it is on a single product. Led by Khosla Ventures with participation from a16z speedrun and several other funds, the financing signals that continuous hormone tracking is emerging as a serious frontier in women’s health wearables. According to Rock Health’s Consumer Adoption Survey, 57% of Americans already own a wearable or connected device, which means growth now depends on deeper insight, not more step counters. Investors are betting that an endocrine-focused, noninvasive wearable health device can supply that insight and build large-scale longitudinal datasets. “We believe women’s health should be proactive, data-driven, and deeply personalized,” said Emily Bennett of a16z speedrun, highlighting the appeal of AI health monitoring that goes beyond fitness metrics to explain why physiology fluctuates day to day.
Rethinking Female Physiology Through Continuous Data
Clair’s early modeling hints that female physiology may be more complex than widely taught. In beta testing, the company reports identifying nine distinct hormonal sub-phases in the menstrual cycle, more than double the usual four-phase framework. Co-founder and CTO Abhinav Agarwal says continuous modeling of the hypothalamic–pituitary–ovarian axis shows the ovary moving through dynamic stages that episodic tests struggle to capture. This suggests that textbook cycles may oversimplify how hormones ebb and flow, which could have implications for fertility timing, athletic performance, PCOS management and perimenopause care. Instead of asking what hormones look like on a single lab day, continuous hormone tracking reveals trajectories and inflection points. If independent validation supports these nine sub-phases, clinicians may need to update diagnostic windows, treatment thresholds and even how they explain “normal” to patients, shifting from rigid phases to flexible, individualized patterns.
Noninvasive Design, Daily Wear and Clinical Implications
Clair’s jewelry-inspired design is deliberate: the wearable must be comfortable and socially acceptable if it is to gather months of hormone data without disruption. By avoiding blood draws and urine tests, the device lowers barriers for frequent use, opening the door to longitudinal datasets that capture puberty, cycle irregularities, pregnancy attempts, perimenopause and beyond. For clinicians, continuous hormone tracking could complement lab tests by providing context between visits: how often cycles shift, how quickly progesterone falls, or how sleep and heart rate variability correlate with endocrine changes. For users, the promise is personalized insights rather than generic cycle averages, with AI health monitoring translating noisy physiological signals into clear patterns. Noninvasive wearable health technology also raises new questions: which patterns are clinically actionable, how to integrate this data into care pathways, and how to prevent overinterpretation of normal variability.
